|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/724 | |
| A61K 9/20 | |||
| A61K 9/28 | |||
| A61K 9/48 | |||
| A61K 31/202 |
| (11) | Patento numeris | 2575487 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 11790107.4 |
| Europos patento paraiškos padavimo data | 2011-06-02 | |
| (97) | Europos patento paraiškos paskelbimo data | 2013-04-10 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-10-18 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2011/000997 |
| Data | 2011-06-02 |
| (87) | Numeris | WO 2011/152869 |
| Data | 2011-12-08 |
| (30) | Numeris | Data | Šalis |
| 350804 P | 2010-06-02 | US |
| (72) |
GAINER, John, L., US
MURRAY, Robert, US
|
| (73) |
Diffusion Pharmaceuticals Llc,
2020 Avon Court 4, Charlottesville, VA 22902,
US
|
| (54) | ORAL FORMULATIONS OF BIPOLAR TRANS CAROTENOIDS |
| ORAL FORMULATIONS OF BIPOLAR TRANS CAROTENOIDS |